Complete Care at Brackenville: Medication Errors - DE
The resident, identified as R2 in inspection records, was admitted June 27 with muscle weakness, bladder cancer and ocular myasthenia gravis. The facility prescribed pyridostigmine bromide tablets twice daily to treat the myasthenia gravis, a condition that causes severe muscle weakness and can affect breathing and swallowing.
Federal inspectors found the resident had refused the medication 28 times out of 49 opportunities between June 28 and July 22. Testing showed the resident was completely cognitively intact with a score of 15 on the Brief Interview for Mental Status.
Despite the consistent refusals of essential medication, the facility failed to create any care plan addressing how to handle the situation.
Myasthenia gravis attacks the connection between nerves and muscles, causing weakness that can worsen throughout the day. Pyridostigmine bromide helps improve muscle strength by preventing the breakdown of acetylcholine, a chemical that transmits signals from nerves to muscles. Without treatment, patients can experience severe weakness affecting their ability to chew, swallow, speak or breathe.
The inspection occurred September 15 following a complaint. When inspectors reviewed clinical records on September 12, they found no evidence of any care plan for medication refusal.
The Director of Nursing confirmed the finding during an interview that same day at 1:00 PM.
Federal regulations require nursing homes to develop person-centered care plans that address all resident needs, including strategies for handling medication refusals. These plans must include specific approaches tailored to each resident's preferences, medical needs and cognitive status.
For a cognitively intact resident like R2, a care plan might include education about the medication's importance, alternative timing or administration methods, or involvement of family members or physicians in discussions about treatment options.
The facility's failure becomes more significant given the resident's diagnosis. Ocular myasthenia gravis specifically affects the muscles controlling eye movement and eyelid function, but can progress to generalized myasthenia gravis affecting breathing and swallowing muscles. Consistent medication adherence is crucial for preventing dangerous complications.
The inspection records show the resident was offered the medication 49 times over the 25-day period, suggesting staff recognized the importance of the treatment. However, with no systematic approach to address the refusals, the pattern continued unchanged.
Care plans for medication refusal typically require input from physicians, nursing staff, social workers and the resident themselves. They should identify potential reasons for refusal, alternative approaches to administration, and monitoring protocols to ensure resident safety when medications are refused.
The facility's administration, including the Nursing Home Administrator and Director of Nursing, acknowledged the deficiency during an exit conference September 15 at 3:15 PM.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm, affecting few residents. However, the finding represents a fundamental failure in individualized care planning required under federal nursing home regulations.
Complete Care at Brackenville must now submit a plan of correction detailing how it will address the deficiency and prevent similar failures. The facility has not yet provided its corrective action plan.
The inspection occurred nearly three months after the medication refusal pattern was documented, raising questions about how long the resident went without proper care planning for this critical issue.
For R2, the summer months passed with essential medication refused more than half the time, while facility staff had no systematic approach to address the potentially dangerous pattern.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Complete Care At Brackenville LLC from 2025-09-15 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
COMPLETE CARE AT BRACKENVILLE LLC in HOCKESSIN, DE was cited for violations during a health inspection on September 15, 2025.
The resident, identified as R2 in inspection records, was admitted June 27 with muscle weakness, bladder cancer and ocular myasthenia gravis.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.